Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | PYGL | P06737 | 2/20 | 0.44 |
| ▸ | PYGM | P11217 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5665607 | 1.00 | RAB9A (0.47) | RAB9ATDP1POLBMEN1KMT2A | |
| SCHEMBL14578387 | 0.84 | TDP1 (0.69) | RAB9ATDP1POLBKMT2ANPC1 | |
| SCHEMBL14880230 | 0.79 | RAB9A (0.63) | RAB9ATDP1POLBMEN1KMT2A | |
| SCHEMBL14578172 | 0.75 | TDP1 (0.65) | RAB9ATDP1POLBMEN1KMT2A | |
| SCHEMBL14578382 | 0.74 | TDP1 (0.64) | RAB9ATDP1POLBMEN1KMT2A | |
| SCHEMBL5263400 | 0.73 | TDP1 (0.53) | RAB9ATDP1POLBMEN1KMT2A | |
| SCHEMBL14578388 | 0.73 | TDP1 (0.61) | RAB9ATDP1POLBKMT2ANPC1 | |
| SCHEMBL14880113 | 0.73 | ALDH1A1 (0.73) | RAB9APOLBMEN1KMT2ANPC1 | |
| SCHEMBL3025986 | 0.71 | TDP1 (0.58) | RAB9ATDP1POLBKMT2ANPC1 | |
| SCHEMBL3025988 | 0.71 | TDP1 (0.58) | RAB9ATDP1POLBKMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070299115-A1 | (Hetero)Cyclyl(Thio) Carboxylic Acid Anilides For Controlling Pathogenic Fungi | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070299115-A1 | (Hetero)Cyclyl(Thio) Carboxylic Acid Anilides For Controlling Pathogenic Fungi | CBR3, TST, HAO2 | RAB9A 2681/4885TDP1 4298/4885POLB 4253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.